The following is a summary of the Aimia Inc. (AIMFF) Q1 2024 Earnings Call Transcript:

Financial Performance:

• Aimia's Q1 consolidated revenue grew 22% to $122 million.

• Gross margins improved to 28.3% from 23.8%.

• Adjusted EBITDA was $6.7 million, representing a turnaround from Q4's EBITDA loss of $4 million.

• Net loss has improved to $4.2 million from $59 million in Q4 2023.

• Revenue growth came largely from subsidiaries Bozzetto, Cortland, and StarChem, with StarChem adding $7.3 million of revenue and $1.5 million of adjusted EBITDA in Q1.

Business Progress:

• Aimia monetized more than $11 million worth of Capital A shares in Q1.

• Early January saw the closure of StarChem's acquisition, contributing to revenue and adjusted EBITDA growth.

• Cortland International also experienced growth due to stronger customer demand and an improved product mix.

• Despite some decline, Aimia ended Q1 with $98.2 million in cash and cash equivalents.

• The company anticipates adjusted EBITDA for Bozzetto and Cortland to be in the range of $80 million to $85 million for this fiscal year.

• Aimia has plans to focus on unlocking the growth potential of Bozzetto and Cortland, monetizing non-core assets responsibly, and capital structure optimization in 2024. They aim to return capital through a normal course issuer bid later this year.

More details: AIMIA INC IR

Tips: For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.